Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/34905

Title:	Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial.
Authors:	Garcia-Arumi, Jose Gómez-Ulla, Francisco Amparo, Navea Cervera, Enrique Fonollosa, Alex Arias, Luis Araiz, Javier Donate, Juan de Figueroa, Marta Suárez Manzanas, Lucia Crespí, Jaume Gallego, Roberto View more
Issue Date:	2018
Citation:	J Ophthalmol.2018;(2018):8310350
Abstract:	To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO).
PMID:	30405907
URI:	https://hdl.handle.net/20.500.12530/34905
Rights:	openAccess
ISSN:	2090-004X
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

File	Description	Size	Format
PMC6204200.pdf		1.09 MB	Adobe PDF	View/Open